OCX Company Profile and Key Details

Q: Who are the executives of OCX?

Ms. Sara RiordanDirector of Medical EducationMs. Gisela A. PaulsenChief Operating Officer & PresMr. Anish JohnChief Financial OfficerMr. James LiuSenior Director, Controller, Principal Accounting Officer & Interim Principal Financial OfficerDr. Douglas T. Ross M.D., Ph.D.Chief Science OfficerMr. Ronald A. Andrews Jr.ConsultantMr. Robert S. SeitzHead of Immune OncologyMs. Sandra O'DonaldSenior Vice President of Bus. OperationsDr. Ekkehard Schutz M.D., Ph.D.Chief Science OfficerMr. Yuh-Min Chiang Ph.D.Senior Vice President of R&D and Product Devel.Mr. Joshua RiggsPres, Chief Executive Officer & DirectorPeter HongSec.Mr. William AnnettPres & Chief Executive Officer of OncoCyte CorporationDr. Michael D. West Ph.D.Founder, Pres, Chief Executive Officer & Director

NASDAQ : OCX

OncoCyte

$3.20

0.47+17.22%

At Close 4:00 PM

Not Actively Trading

68.29

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

OncoCyte Corporation (OCX) stock surged +17.22%, trading at $3.20 on NASDAQ, up from the previous close of $2.73. The stock opened at $2.82, fluctuating between $2.82 and $3.20 in the recent session.

Stock Snapshot

2.73

Prev. Close

91.52M

Market Cap

2.82

Day Low

-0.8443271767810027

P/E Ratio

-3.79

EPS (TTM)

-2.86

Cash Flow per Share

2.82

Open

28.6M

Number of Shares

3.2

Day High

27.12%

Free Float in %

3.1

Book Value

100.56K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 10, 2025	2.94	3.03	2.85	2.89	33.4K
Jul 08, 2025	3.03	3.05	2.91	2.91	30.45K
Jun 25, 2025	3.46	3.46	3.23	3.34	69.54K
Jun 24, 2025	3.68	3.68	3.33	3.45	140.31K
Jun 23, 2025	3.75	4.14	3.35	3.66	313.25K
Jun 17, 2025	2.77	3.20	2.71	3.20	99.94K
Jun 16, 2025	2.73	2.90	2.65	2.73	42.84K
Jun 13, 2025	2.83	2.83	2.60	2.65	17.56K
Jun 12, 2025	2.64	2.76	2.56	2.70	53.06K
Jun 11, 2025	2.75	2.81	2.64	2.64	47.94K
Jun 10, 2025	2.80	2.89	2.76	2.76	17.71K
Jun 09, 2025	2.91	2.94	2.61	2.78	76.71K
Jun 05, 2025	2.96	3.15	2.90	2.97	30.19K
Jun 04, 2025	3.13	3.13	2.93	2.93	40.51K
Jun 03, 2025	3.16	3.17	3.00	3.07	17.14K
Jun 02, 2025	3.37	3.40	3.11	3.19	32.68K
May 30, 2025	3.22	3.32	3.19	3.32	14.32K
May 29, 2025	3.32	3.32	3.24	3.26	5.18K
May 28, 2025	3.29	3.35	3.26	3.33	38K
May 27, 2025	3.40	3.40	3.22	3.25	38.23K

Contact Details

Irvine, CA 92618

United States

https://imdxinc.com 949 409 7600

About Company

OncoCyte Corporation is a molecular diagnostics firm that conceptualizes, refines, and brings to market its exclusive laboratory-developed tests aimed at identifying cancer in patients, serving both the United States and global markets. The company's portfolio features DetermaRx, a specialized molecular test for detecting early-stage adenocarcinoma in the lung, alongside DetermaIO, a unique proprietary assay that assesses gene expression. In addition to its diagnostic offerings, OncoCyte provides a suite of services including biomarker discovery, the design and development of new assays, and essential support for clinical trials. It also delivers various biomarker testing solutions specifically tailored for pharmaceutical companies. OncoCyte has established a collaborative agreement with Life Technologies Corporation. This partnership is geared towards the co-development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, which are designed for use with the Ion Torrent Genexus integrated sequencer and purification system. The corporation was founded in 2009 and its primary base of operations is situated in Irvine, California.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current OncoCyte Corporation (OCX) stock price?

OncoCyte Corporation (NASDAQ: OCX) stock price is $3.20 in the last trading session. During the trading session, OCX stock reached the peak price of $3.20 while $2.82 was the lowest point it dropped to. The percentage change in OCX stock occurred in the recent session was 17.22% while the dollar amount for the price change in OCX stock was $0.47.

OCX's industry and sector of operation?

The NASDAQ listed OCX is part of Biotechnology industry that operates in the broader Healthcare sector. OncoCyte Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OCX?

Ms. Sara Riordan
Director of Medical Education
Ms. Gisela A. Paulsen
Chief Operating Officer & Pres
Mr. Anish John
Chief Financial Officer
Mr. James Liu
Senior Director, Controller, Principal Accounting Officer & Interim Principal Financial Officer
Dr. Douglas T. Ross M.D., Ph.D.
Chief Science Officer
Mr. Ronald A. Andrews Jr.
Consultant
Mr. Robert S. Seitz
Head of Immune Oncology
Ms. Sandra O'Donald
Senior Vice President of Bus. Operations
Dr. Ekkehard Schutz M.D., Ph.D.
Chief Science Officer
Mr. Yuh-Min Chiang Ph.D.
Senior Vice President of R&D and Product Devel.
Mr. Joshua Riggs
Pres, Chief Executive Officer & Director
Peter Hong
Sec.
Mr. William Annett
Pres & Chief Executive Officer of OncoCyte Corporation
Dr. Michael D. West Ph.D.
Founder, Pres, Chief Executive Officer & Director

How OCX did perform over past 52-week?

OCX's closing price is 66.49% higher than its 52-week low of $1.92 where as its distance from 52-week high of $4.75 is -32.63%.

How many employees does OCX have?

Number of OCX employees currently stands at 46.

Link for OCX official website?

Official Website of OCX is: https://imdxinc.com

How do I contact OCX?

OCX could be contacted at phone 949 409 7600 and can also be accessed through its website. OCX operates from 15 Cushing, Irvine, CA 92618, United States.

How many shares of OCX are traded daily?

OCX stock volume for the day was 100.56K shares. The average number of OCX shares traded daily for last 3 months was 76.06K.

What is the market cap of OCX currently?

The market value of OCX currently stands at $91.52M with its latest stock price at $3.20 and 28.6M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	46
Beta	0.99
Sales or Revenue	$1.50M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	46
Beta	0.99
Sales or Revenue	$1.50M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

OCX Company Profile and Key Details

OncoCyte

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics